Botulinum toxin a for oral cavity cancer patients: In microsurgical patients BTX injections in major salivary glands temporarily reduce salivary production and the risk of local complications related to saliva stagnation

Toxins

Volumn 4, Issue 11, 2012, Pages 956-961

  Corradino, Bartolo ^a   Di Lorenzo, Sara ^a   Moschella, Francesco ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

Botulinum toxin; Forearm free flap; Free flap complications; Oral cancer; Oro cutaneous fistula; Saliva related complications; Salivary major glands; Salivary production

Indexed keywords

BOTULINUM TOXIN A; TECHNETIUM 99M;

ARTICLE; CANCER SURGERY; CLINICAL ARTICLE; FREE TISSUE GRAFT; HUMAN; MICROSURGERY; MOUTH CANCER; MOUTH DISEASE; NECK DISSECTION; PAROTID GLAND; POSTOPERATIVE COMPLICATION; SALIVARY GLAND; SALIVARY GLAND SCINTISCANNING; SALIVATION; SUBMANDIBULAR GLAND; WOUND DEHISCENCE; XEROSTOMIA;

BOTULINUM TOXINS, TYPE A; HUMANS; MICROSURGERY; MOUTH NEOPLASMS; POSTOPERATIVE COMPLICATIONS; RADIONUCLIDE IMAGING; RECONSTRUCTIVE SURGICAL PROCEDURES; SALIVA; SALIVARY GLANDS; SIALORRHEA; SURGICAL FLAPS; TREATMENT OUTCOME;

FISTULA;

EID: 84870497049     PISSN: 20726651     EISSN: None     Source Type: Journal    
DOI: 10.3390/toxins4110956     Document Type: Article

References (11)

1. Conway, D.I.; Stockton, D.L.; Warnakulasuriya, K.A.A.S.; Ogden, G.; Macpherson, L.M.D. Incidence of oral and oropharyngeal cancer in the United Kingdom. Oral Oncol. 2006, 42, 586-592.
2. Franceschi, S.; Bidoli, E.; Herrero, R.; Munoz, N. Comparison of cancers of the oral cavity and pharynx worldwide: Etiological clues. Oral Oncol. 2000, 36, 106-115.
3. Salgado, C.J.; Mardini, S.; Chen, H.; Chen, S. Critical oropharyngocutaneous fistulas after microsurgical head and neck reconstruction: Indications for management using the tissueplug technique. Plast. Reconstr. Surg. 2003, 112, 957-963.
4. Friedman, A.; Potulska, A. Quantitative assessment of parkinsonian sialorrhea and results of treatment with botulinum toxin. Parkinsonism Relat. Disord. 2001, 7, 329-332.
5. Bothwell, J.E.; Clarke, K.; Dooley, J.M.; Gordon, K.E.; Anderson, R.; Wood, E.P.; et al. Botulinum toxin A as a treatment for excessive drooling in children. Pediatr. Neurol. 2002, 27, 18-22.
6. Monnier, G.; Tatu, L.; Parratte, B.; Cosson, A.; Michel, F.; Metton, G. Sialorrhea, hyperhidrosis and botulinum toxin (In French). Ann. Readapt. Med. Phys. 2003, 46, 338-345.
7. Arad, A.; Blitzer, A. Botulinum toxin in the treatment of autonomic nervous system disorders. Head Neck Surg. 2004, 15, 118-121.
8. Ellies, M.; Laskawi, R.; Rohrbach-Volland, S.; Arglebe, C. Up-to-date report of botulinum toxin therapy in patients with drooling caused by different etiologies. J. Oral Maxillofac. Surg. 2003, 61, 454-457.
9. Dogu, O.; Apaydin, D.; Sevim, S.; Talas, D.U.; Aral, M. Ultrasound-guided versus "blind" intraparotid injections of botulinum toxin-A for the treatment of sialorrhoea in patients with Parkinson's disease. Clin. Neurol. Neurosurg. 2004, 106, 93-96.
10. Malpani, B.L.; Jaiswar, R.K.; Samuel, A.M. Noninvasive scintigraphic method to quantify unstimulated secretions from individual salivary glands. Auris Nasus Larynx 1999, 26, 453-456.
11. Corradino, B.; di Lorenzo, S.; Mossuto, C.; Costa, R.P.; Moschella, F. Botulinum toxin in preparation of oral cavity for microsurgical reconstruction. Acta Oto-Laryngol. 2010, 130, 156-160.